Lanlan Pan

797 total citations
31 papers, 559 citations indexed

About

Lanlan Pan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lanlan Pan has authored 31 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lanlan Pan's work include Gastric Cancer Management and Outcomes (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Lung Cancer Research Studies (5 papers). Lanlan Pan is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Lung Cancer Research Studies (5 papers). Lanlan Pan collaborates with scholars based in China, United States and Hong Kong. Lanlan Pan's co-authors include Qianbing Wan, Xibo Pei, Jian Wang, Rui He, Pengzhi Dong, Xiaoxuan Tian, Xiting Zhang, Xue Li, Lehui Xiao and Zhongju Ye and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Endocrinology.

In The Last Decade

Lanlan Pan

31 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Pan China 10 206 193 115 101 59 31 559
Ting Mei China 11 228 1.1× 221 1.1× 102 0.9× 117 1.2× 73 1.2× 46 589
Puja Panwar Hazari India 17 139 0.7× 227 1.2× 95 0.8× 136 1.3× 72 1.2× 70 826
Jiaxin Sun China 13 193 0.9× 201 1.0× 65 0.6× 91 0.9× 53 0.9× 26 497
Jilai Tian China 16 201 1.0× 245 1.3× 78 0.7× 155 1.5× 102 1.7× 32 720
Shaymaa Mousa United States 11 137 0.7× 237 1.2× 176 1.5× 145 1.4× 58 1.0× 18 778
Chuanchao Du China 11 175 0.8× 157 0.8× 78 0.7× 78 0.8× 34 0.6× 25 409
Sui Li-hua China 12 251 1.2× 357 1.8× 196 1.7× 105 1.0× 78 1.3× 24 812
Jamileh Kadkhoda Iran 12 304 1.5× 148 0.8× 102 0.9× 171 1.7× 74 1.3× 14 544
Liuwei Zhang China 14 293 1.4× 201 1.0× 199 1.7× 106 1.0× 34 0.6× 54 684

Countries citing papers authored by Lanlan Pan

Since Specialization
Citations

This map shows the geographic impact of Lanlan Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Pan more than expected).

Fields of papers citing papers by Lanlan Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Pan. The network helps show where Lanlan Pan may publish in the future.

Co-authorship network of co-authors of Lanlan Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Pan. A scholar is included among the top collaborators of Lanlan Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Pan. Lanlan Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Wenwen, et al.. (2025). Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer. Cancer Immunology Immunotherapy. 74(4). 124–124. 3 indexed citations
2.
Kang, Wenwen, Jing Cheng, Lanlan Pan, et al.. (2024). Heterogeneity between subgroups of first-line chemoimmunotherapy for extensive-stage small cell lung cancer patients: a meta-analysis and systematic review. Frontiers in Oncology. 14. 1334957–1334957. 1 indexed citations
3.
Li, Yu, Lanlan Pan, Jun Yao, et al.. (2024). First‐line chemoimmunotherapy for patients with small‐cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis. Thoracic Cancer. 15(34). 2437–2448. 3 indexed citations
4.
Pan, Lanlan, Wei Yu, Xia Shen, et al.. (2024). 799MO The primary results from a randomized double-blind phase II study of rovadicitinib versus hydroxyurea in patients with myelofibrosis. Annals of Oncology. 35. S596–S596. 1 indexed citations
5.
6.
Liu, Qiuping, Jie Tang, Yizhang Chen, et al.. (2023). Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial. JHEP Reports. 5(7). 100763–100763. 3 indexed citations
7.
8.
Pan, Lanlan, et al.. (2022). Development of a lncRNA‐based prognostic signature for oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 51(4). 358–368. 6 indexed citations
9.
10.
Pan, Lanlan, et al.. (2022). Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors. Medicine. 101(25). e29364–e29364. 2 indexed citations
11.
Pan, Lanlan, Xiaolin Yang, Honglan Qi, et al.. (2022). Sensitive and rapid determination of heat shock protein 70 using lateral flow immunostrips and upconversion nanoparticle fluorescence probes. The Analyst. 147(15). 3444–3450. 5 indexed citations
12.
Li, Min, Tiwei Fu, Lanlan Pan, et al.. (2021). Agarose-based spheroid culture enhanced stemness and promoted odontogenic differentiation potential of human dental follicle cells in vitro. In Vitro Cellular & Developmental Biology - Animal. 57(6). 620–630. 20 indexed citations
13.
Zhao, Fengjiao, et al.. (2021). Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer. OncoTargets and Therapy. Volume 14. 1873–1882. 7 indexed citations
14.
Pan, Lanlan, et al.. (2020). Lateral flow immunostrips for the sensitive and rapid determination of 8-hydroxy-2′-deoxyguanosine using upconversion nanoparticles. Microchimica Acta. 187(7). 377–377. 9 indexed citations
15.
Pan, Lanlan, et al.. (2019). KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients. The Breast. 44. S90–S90. 2 indexed citations
16.
He, Shuang, Hao Guo, Rongrong Chen, et al.. (2019). A Defined Combination of Four Active Principles From the Danhong Injection Is Necessary and Sufficient to Accelerate EPC-Mediated Vascular Repair and Local Angiogenesis. Frontiers in Pharmacology. 10. 1080–1080. 14 indexed citations
17.
Dong, Pengzhi, Lanlan Pan, Xiting Zhang, et al.. (2017). Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice. Journal of Ethnopharmacology. 198. 479–488. 51 indexed citations
18.
He, Rui, Xibo Pei, Lanlan Pan, et al.. (2013). EFFECTS OF ULTRASONIC RADIATION INTENSITY ON THE OXIDATION OF SINGLE-WALLED CARBON NANOTUBES IN A MIXTURE OF SULFURIC AND NITRIC ACIDS. NANO. 8(4). 1350040–1350040. 7 indexed citations
19.
Pan, Lanlan, Xibo Pei, Rui He, Qianbing Wan, & Jian Wang. (2012). Multiwall carbon nanotubes/polycaprolactone composites for bone tissue engineering application. Colloids and Surfaces B Biointerfaces. 93. 226–234. 162 indexed citations
20.
Pei, Xibo, Lanlan Pan, Rui He, et al.. (2012). The recombinant human dentin matrix protein 1-coated titanium and its effect on the attachment, proliferation and ALP activity of MG63 cells. Journal of Materials Science Materials in Medicine. 23(11). 2717–2726. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting Mei Breakdown of academic impact, for papers by Puja Panwar Hazari Breakdown of academic impact, for papers by Jiaxin Sun Breakdown of academic impact, for papers by Jilai Tian Breakdown of academic impact, for papers by Shaymaa Mousa Breakdown of academic impact, for papers by Chuanchao Du Breakdown of academic impact, for papers by Sui Li-hua Breakdown of academic impact, for papers by Jamileh Kadkhoda Breakdown of academic impact, for papers by Liuwei Zhang
Rankless by CCL
2026